Fewer than 10% of individuals that would benefit from GLP-1 drugs including Wegovy are able to get them, states the World Health Organization as it issues its inaugural recommendations on the drugs.
With in excess of 1,000,000,000 individuals worldwide now classified as obese, it is calling for more widespread and fairer availability to GLP-1 medication.
Per projections, over two billion are projected to be living with obesity by 2030 if no action is taken.
"The latest guidance recognises that obesity is a long-term condition that can be treated with thorough and ongoing support," said its chief Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and distribution challenges are significant barriers to universal availability to the injections that can help people shift considerable body mass, explains the organization.
Despite the present best projected scenario, the production of GLP-1 therapies could only cover approximately 100 million people โ under 10% of the global need, as stated by the WHO.
The recommendation urges countries and companies to widen access, through measures such as patent sharing.
The intellectual property rights on the active ingredient โ the primary ingredient of Novo Nordisk's Wegovy โ is due to expire in several nations in 2026.
The injections replicate a biological compound to delay gastric emptying, curb appetite and enhance satiety so users reduce food intake.
Individuals typically start to lose weight in the initial weeks of beginning the regular doses.
Studies suggests people may put most of the weight back on within a year of stopping the treatment, as their usual hunger come back.
To be overweight or obese elevates your chance for contracting medical conditions, including diabetes, cardiovascular issues, stroke, and certain malignancies.
Obesity concerns people in every country and was associated with millions of deaths worldwide in 2024, as per the WHO.
Lena de Vries is a Dutch food writer and recipe developer who loves blending traditional flavors with modern twists.